Paddy Stone was appointed to his first senior academic appointment at SGUL in 2001. He now leads an internationally recognized multi-disciplinary academic department of palliative and end of life care research at UCL.

Since 2000 he has obtained over £6 million in peer-reviewed research income. He has successfully completed one of the largest prospective (n=1018) multi-centre palliative care studies (involving 18 sites across England) and published in the BMJ. He is the Chief Investigator on two large NIHR HTA funded grants: The PiPS2 study on prognostic indicators in palliative care (£832k); and MePFAC, a double blind randomised placebo controlled study of methylphenidate for cancer related fatigue (£1.4M). His total number of peer-reviewed publications is >100. His H-index is 37 (Google scholar). He has supervised five full-time PhD students to completion in regulation time and is currently supervising five further full time students.

Paddy Stone has been involved in the development of palliative medicine as an academic discipline. He was Chair of the Science Committee of the Association of Palliative Medicine (APM). He was a member of the NCRI Palliative Care Studies Group. He was Chair of the prognosis working group and a member of the cachexia  and dyspnoea sub-groups. He was secretary of the Palliative Care Research Society for five years. He has formed research collaborations both nationally and internationally and his role as a research leader has been recognized by invitations to speak at international meetings and to serve on committees of learned and professional societies.